185 related articles for article (PubMed ID: 32110561)
1. Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals.
Patil YB; Garg R; Rajguru JP; Sirsalmath M; Bevinakatti VA; Kumar M; Sharma S
J Family Med Prim Care; 2020 Jan; 9(1):31-35. PubMed ID: 32110561
[TBL] [Abstract][Full Text] [Related]
2. Vogt-Koyanagi-Harada syndrome.
Greco A; Fusconi M; Gallo A; Turchetta R; Marinelli C; Macri GF; De Virgilio A; de Vincentiis M
Autoimmun Rev; 2013 Sep; 12(11):1033-8. PubMed ID: 23567866
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada Disease: A Narrative Review.
Tayal A; Daigavane S; Gupta N
Cureus; 2024 Apr; 16(4):e58867. PubMed ID: 38800227
[TBL] [Abstract][Full Text] [Related]
4. Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders.
Egbeto IA; Garelli CJ; Piedra-Mora C; Wong NB; David CN; Robinson NA; Richmond JM
Front Immunol; 2020; 11():590558. PubMed ID: 33384688
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease.
DiPreta EA; Smith KJ; Williams J; Skelton AH
J Cutan Med Surg; 2000 Jul; 4(3):156-60. PubMed ID: 11003722
[TBL] [Abstract][Full Text] [Related]
6. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
Lavezzo MM; Sakata VM; Morita C; Rodriguez EE; Abdallah SF; da Silva FT; Hirata CE; Yamamoto JH
Orphanet J Rare Dis; 2016 Mar; 11():29. PubMed ID: 27008848
[TBL] [Abstract][Full Text] [Related]
7. Successful cochlear implantation in a case of Vogt-Koyanagi-Harada disease.
Sydlowski SA; Luffler C; Haberkamp T
Otol Neurotol; 2014 Oct; 35(9):1522-4. PubMed ID: 24770410
[TBL] [Abstract][Full Text] [Related]
8. New insights into Vogt-Koyanagi-Harada disease.
Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH
Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
Okada T; Sakamoto T; Ishibashi T; Inomata H
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
[TBL] [Abstract][Full Text] [Related]
10. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada Syndrome - A Neurologist's Perspective.
Shivaram S; Nagappa M; Seshagiri DV; Shanthakumar JS; Panda SS; Anadure R; Nandeesh BN; Chickabasaviah YT; Bharath RD; Vijayan J; Kashyap B; Sinha S; Taly AB
Ann Indian Acad Neurol; 2021; 24(3):405-409. PubMed ID: 34447006
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia.
Iqniebi A; Gaafar A; Sheereen A; Al-Suliman A; Mohamed G; Al-Hussein K; Tabbara KF
Mol Vis; 2009 Sep; 15():1876-80. PubMed ID: 19756183
[TBL] [Abstract][Full Text] [Related]
13. [A rare case of ocular scarrings in a patient with Vogt-Koyanagi-Harada disease].
Belmokhtar A; Daoudi R
Pan Afr Med J; 2017; 28():313. PubMed ID: 29721143
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.
Aisenbrey S; Lüke C; Ayertey HD; Grisanti S; Perniok A; Brunner R
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):996-9. PubMed ID: 14618342
[TBL] [Abstract][Full Text] [Related]
15. Vogt-Koyanagi-Harada syndrome: Association with alopecia areata.
Haque WM; Mir MR; Hsu S
Dermatol Online J; 2009 Dec; 15(12):10. PubMed ID: 20040260
[TBL] [Abstract][Full Text] [Related]
16. Vogt-Koyanagi-Harada Syndrome in a Ugandan: Diagnostic and Therapeutic Challenges.
Bongomin F; Onen FS; Kaddumukasa M
Case Rep Med; 2019; 2019():5192754. PubMed ID: 31636673
[TBL] [Abstract][Full Text] [Related]
17. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
18. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment.
Du L; Kijlstra A; Yang P
Prog Retin Eye Res; 2016 May; 52():84-111. PubMed ID: 26875727
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response directed against LEDGF in patients with VKH.
Yamada K; Senju S; Shinohara T; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
Immunol Lett; 2001 Oct; 78(3):161-8. PubMed ID: 11578690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
